查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1912423

医药市场PET包装：按包装类型、药品类型、填充和封装工艺、永续性解决方案以及最终用户划分－2026年至2032年全球市场预测

PET Packaging In the Pharmaceutical Market by Packaging Type, Drug Type, Fill-Finish, Sustainability Solution, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医药 PET 包装市场规模将达到 65.6 亿美元，到 2026 年将达到 71 亿美元，到 2032 年将达到 123.2 亿美元，复合年增长率为 9.40%。

关键市场统计数据
基准年 2025 65.6亿美元
预计年份：2026年 71亿美元
预测年份 2032 123.2亿美元
复合年增长率 (%) 9.40%

针对PET药品包装的策略方法，为供应链领导者阐明监管重点、材料性能权衡以及营运影响。

製药业面临严格的监管、复杂的供应链和不断变化的患者期​​望，而包装是支撑这一切的关键组成部分。聚对苯二甲酸乙二醇酯（通常称为PET）已成为一种用途广泛的材料，它能够支援日益丰富的药物剂型，同时兼顾阻隔功能、可製造性和成本效益。本分析清楚地阐述了包装决策的重要性，它不仅关乎内容物的盛装，还会影响低温运输物流、剂量准确性、患者依从性以及在监管检查中证明合规性的能力。

监管重点、材料创新和永续性需求如何融合，重新定义PET包装的设计、製造和供应策略

由于三大因素的共同作用，PET药品包装市场正经历变革性的转变：日益严格的监管、技术的创新以及永续性的迫切需求。在监管方面，监管机构日益重视可萃取物和可浸出物测试、序列化防伪以及包装相容性认证，迫使製造商采用更严格的材料评估和文件记录方法。同时，阻隔涂层、共聚物配方和积层製造技术的进步，使得PET能够应用于以往由玻璃和HDPE主导的领域，从而拓展了药品包装容器的组合范围。

不断变化的关税政策如何影响全球供应链中的药品包装采购、供应商选择策略和弹性规划

关税环境和贸易政策的调整将对筹资策略、供应商选择和区域製造地地点产生重大影响。在美国，近期政策週期中引入的关税变化正促使製药公司和包装供应商重新思考其筹资策略，探索近岸外包方案，并增强供应链的韧性。这些措施促使他们重新评估总到岸成本 (TLC) 的计算方法，不再仅仅关注单位成本，而是将前置作业时间、库存缓衝以及与合格替代供应商相关的营运成本也纳入考虑。

一个全面的细分框架，用于识别材料、规格、填充/表面处理和永续性之间的权衡取舍，以指导包装开发和采购决策。

深入的細項分析突显了包装类型、药物剂型、最终用户、填充/包装方法以及永续性偏好如何导致技术要求和商业性优先事项的差异。基于包装类型，此细分市场分为安瓿/管瓶、泡壳包装、瓶装和注射器/药筒。瓶装进一步细分为多剂量和单剂量规格，注射器/药筒则分为药筒和预填充式注射器。这种分类方案揭示了对阻隔性能、剂量精度和密封系统的需求如何驱动材料选择和二级包装设计。

区域监管差异、製造地集中度和永续性政策如何为全球PET包装市场带来不同的策略要务

区域趋势对原料供应、监管预期和供应链结构有显着影响。在美洲，复杂生物製药的高普及率以及成熟的法规环境（强调序列化和全面的包装验证）正在塑造需求模式，促使企业投资于完善的品质系统和本地供应商资格认证。北美企业通常优先考虑产品上市速度和透明的供应链，这些优先事项体现在其采购选择和对自动化灌装包装能力的投资。

竞争定位洞察：揭示技术整合、监管严格性和永续性伙伴关係如何定义市场领导地位和供应商差异化

深入观察成熟企业和新兴企业企业，可以发现它们在技术投资、永续性措施和客户参与方面采取了不同的策略。主要企业正专注于建立整合精密成型、先进阻隔解决方案和相容性测试服务的平台，以加快客户认证速度。一些企业也与回收商和材料开发商建立策略合作伙伴关係，以确保稳定的再生PET原料供应，并共同开发符合可萃取性和可浸出性标准的医药级再生材料。

包装领导企业正在采取切实可行的策略步骤，以提高供应商的韧性，加速永续材料的采用，并优化其产品组合中的填充和包装製造流程。

产业领导者应制定一项三管齐下的行动计划，将技术能力、供应链韧性和永续性路径相结合。首先，应优先进行跨职能的资质认证项目，透过双重采购和模组化验证通讯协定降低供应商风险，缩短供应商过渡时间，同时确保产品品质。投资于验证工具包和共用试验框架，可以加快新供应商的引入速度，并减少因更换供应商而造成的营运中断。

采用严谨的混合方法研究，整合专家访谈、技术文献和供应链实证数据，以得出可操作且检验的包装洞察。

本分析所依据的研究采用了多种方法，以平衡的证据为基础得出结论。研究人员透过访谈製药企业和合约包装商的包装工程师、法规事务人员、采购经理和研发经理，收集了第一手数据，以深入了解材料性能、合格要求和操作限制。随后，研究人员将这些定性研究结果与聚合物化学的技术文献、容器相容性法规指南以及已发布的产品规格进行交叉比对，以检验材料性能和相容性声明的准确性。

对技术进步、监管要求和永续性措施如何共同影响製药业领导者的PET包装策略进行综合分析

PET包装在现代医药物流和产品设计中扮演着至关重要的角色，其优异的性能、易加工性和可回收性使其成为多种药物剂型的理想选择。不断变化的监管要求、材料科学的创新以及日益增长的永续性期望，正迫使製造商和供应商重新思考包装架构和供应商关係。这项转变需要严谨的检验，以确保病患安全和产品稳定性，同时也为优化灌装和表面处理工程、降低系统总成本以及满足相关人员对环境绩效的期望创造了机会。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按包装类型分類的药品市场

  • 安瓿瓶与管瓶
  • 泡壳包装
  • 瓶子
    • 多剂量瓶
    • 单剂量瓶
  • 注射器和药筒
    • 墨水匣
    • 预填充式注射器

第九章：按药物类型分類的药品市场

  • 注射
  • 液体
  • 营养补充品
  • 粉末
  • 片剂和胶囊
    • 胶囊
    • 药片

第十章 以填充和包装流程分類的药品市场

  • 自动的
  • 手动的

第十一章：永续解决方案下的医药市场

  • 回收PET
    • 化学回收
    • 机械再生
  • 处女宠物
    • 挤出吹塑成型
    • 射出成型

第十二章：依最终用户分類的药品市场

  • 居家医疗
  • 医院和诊所
  • 零售药房

第十三章：各地区的医药市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：依组别分類的药品市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：各国药品市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章美国医药市场

第十七章：中国医药市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ALPLA Werke Alwin Lehner GmbH & Co KG
  • Amcor plc
  • AptarGroup, Inc.
  • Berry Global, Inc.
  • Catalent, Inc.
  • CCL Industries Inc.
  • Constantia Flexibles GmbH
  • Drug Plastics & Glass Co., Inc
  • Gerresheimer AG
  • Graham Packaging Company
  • Klockner Pentaplast Group GmbH & Co. KG
  • Nipro Corporation
  • Plastipak Packaging, Inc.
  • Silgan Holdings Inc.
Product Code: MRR-AE420CB13993

The PET Packaging In the Pharmaceutical Market was valued at USD 6.56 billion in 2025 and is projected to grow to USD 7.10 billion in 2026, with a CAGR of 9.40%, reaching USD 12.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.56 billion
Estimated Year [2026] USD 7.10 billion
Forecast Year [2032] USD 12.32 billion
CAGR (%) 9.40%

A strategic orientation to PET pharmaceutical packaging that frames regulatory priorities, material performance trade-offs, and operational implications for supply chain leaders

The pharmaceutical industry sits at the intersection of stringent regulation, complex supply chains, and evolving patient expectations, and packaging is a critical enabler of all three. Polyethylene terephthalate, commonly known as PET, has emerged as a versatile material that balances barrier functionality, manufacturability, and cost efficiency while supporting an expanding palette of drug formats. This analysis opens with a clear-eyed overview of why packaging decisions matter beyond containment: they affect cold-chain logistics, dosing integrity, patient adherence, and the ability to demonstrate compliance during regulatory inspections.

Moreover, contemporary pressures such as the drive for sustainable materials, the rise of biologics and prefilled delivery systems, and the need to streamline fill-finish operations are reshaping packaging strategies across the pharmaceutical value chain. The introduction establishes how PET offerings are being engineered to meet sterility requirements, compatibility demands for a range of drug chemistries, and the practicalities of automated assembly lines. It also frames the competing priorities that supply chain leaders and packaging engineers must reconcile, including shelf life versus recyclability and performance versus cost.

The introduction thus sets the stage for an actionable executive summary, clarifying the scope of subsequent sections and establishing the analytical lens through which technology adoption, regional dynamics, and company-level strategies will be evaluated.

How regulatory focus, material innovation, and sustainability imperatives are converging to redefine PET packaging design, manufacturing, and supply strategies

The landscape for PET packaging in pharmaceuticals is undergoing transformative shifts driven by three converging forces: regulatory tightening, technological innovation, and sustainability imperatives. On the regulatory front, agencies are placing greater emphasis on extractables and leachables testing, serialization for anti-counterfeiting, and evidence of packaging compatibility, prompting manufacturers to adopt more rigorous material evaluation and documentation practices. In parallel, technological progress in barrier coatings, co-polymer formulations, and additive manufacturing is enabling PET to address applications previously dominated by glass or HDPE, widening the scope of possible drug-container pairings.

Sustainability has moved from a corporate social responsibility talking point to an operational imperative. Recycled PET pathways, including both mechanical and chemical recycling streams, are being piloted to reduce lifecycle carbon intensity while maintaining pharmaceutical-grade integrity. At the same time, advances in prefilled syringe technologies and cartridge forms are reshaping delivery formats, requiring design-led approaches to PET molding and sealing. These innovations are further amplified by automation trends in fill-finish operations, where end-to-end lines are being reconfigured to minimize human contact and increase throughput without compromising sterility.

Taken together, these shifts are redefining procurement criteria and design priorities. Manufacturers and contract packagers are increasingly selecting packaging solutions through a multidimensional lens that accounts for regulatory evidence, lifecycle impacts, manufacturability, and patient use scenarios.

How evolving tariff policies are reshaping pharmaceutical packaging procurement, supplier qualification strategies, and resilience planning across global supply chains

Tariff environments and trade policy adjustments can materially influence procurement strategies, supplier selection, and regional manufacturing footprints. In the United States, tariff changes prompted in recent policy cycles have incentivized pharmaceutical companies and packaging suppliers to reconsider sourcing strategies, explore nearshoring options, and enhance supply chain resiliency. These dynamics encourage a reassessment of the total landed cost equation that extends beyond unit price to include lead times, inventory buffers, and the operational costs associated with quality qualification of alternate suppliers.

Consequently, procurement teams are increasingly prioritizing supplier diversification and dual sourcing to mitigate the risk of abrupt policy shifts. This has led to strategic investments in supplier qualification programs, longer validation pipelines, and contingency planning for capacity allocation. Where tariffs have increased the friction for imported components, some firms have accelerated localization of critical tooling and mold production, recognizing that upfront capital investment can offset recurrent tariff exposure and reduce vulnerability to trade disruptions.

At the same time, trade dynamics are influencing decisions about sustainable material sourcing. The economics of recycled PET streams can shift with tariff-induced changes to cross-border material flows, affecting the feasibility of certain circularity models. Organizations are therefore adopting scenario planning to understand how tariff policy may interact with sustainability commitments, supply continuity, and long-term supplier partnerships.

A comprehensive segmentation framework that clarifies material, format, fill-finish, and sustainability trade-offs to guide packaging development and procurement decisions

Insightful segmentation analysis highlights how technical requirements and commercial priorities vary by packaging type, drug form, end user, fill-finish method, and sustainability choice. Based on Packaging Type, the landscape is evaluated across ampoules and vials, blister packs, bottles, and syringes and cartridges, with bottles further differentiated into multi-dose and single-dose formats, and syringes and cartridges further delineated into cartridges and pre-filled syringes; this taxonomy helps reveal how barrier needs, dosing accuracy, and closure systems drive material selection and secondary packaging design.

Based on Drug Type, distinctions among injectables, liquids, nutraceuticals, powders, and tablets and capsules inform compatibility testing priorities and contamination risk profiles, while tablets and capsules are examined through the lens of capsule versus tablet formats to identify packaging robustness and labeling requirements. Based on End User, the segmentation across home healthcare, hospitals and clinics, and retail pharmacies sheds light on differing usability and patient safety considerations, such as child-resistant features for retail pharmacies versus high-throughput dispensability for hospitals and clinics.

Based on Fill-Finish, the contrast between automatic and manual processes is instrumental in evaluating container geometry, neck finish tolerances, and sealing technologies that facilitate automated capping and inspection. Based on Sustainability Solution, the choices between recycled PET and virgin PET, with recycled PET further examined through chemical and mechanical recycling paths and virgin PET analyzed by extrusion blow molding versus injection molding methods, reveal trade-offs between material performance, regulatory compliance for pharmaceutical use, and circularity ambitions.

Together, these segmentation lenses enable targeted product development and procurement strategies that align technical specifications with commercial and regulatory priorities.

How cross-regional regulatory divergence, manufacturing density, and sustainability policy create distinct strategic imperatives for PET packaging across global markets

Regional dynamics exert a strong influence on material availability, regulatory expectations, and supply chain architecture. In the Americas, demand patterns are shaped by a high prevalence of complex biologics and a mature regulatory environment that emphasizes serialization and extensive packaging validation, prompting investments in robust quality systems and local supplier qualification. North American players frequently prioritize rapid time to market and transparent supply chains, and these priorities are reflected in sourcing choices and investments in automated fill-finish capacity.

In Europe, the Middle East and Africa, the regulatory landscape is heterogeneous, with leading European jurisdictions advancing ambitious circularity targets while regions within the Middle East and Africa present divergent infrastructure maturity and logistical challenges. These differences drive a mix of centralized production hubs and regional packaging strategies that balance compliance with cost-effective distribution models. Adoption of recycled PET streams in certain European markets is accelerating, influenced by both policy measures and consumer expectations.

In the Asia-Pacific region, dynamics are shaped by large-scale manufacturing ecosystems, a growing domestic pharmaceutical market, and rapid advancement in injection and prefilled device adoption. Supply chain efficiencies and competitive supplier bases have made the region a focal point for tooling and high-volume production, while regulatory harmonization efforts continue to evolve to address material compatibility and serialization across national boundaries. Collectively, regional insights inform decisions about where to locate critical manufacturing steps, how to structure supplier networks, and how to reconcile sustainability commitments with operational realities.

Competitive positioning insights showing how technology integration, regulatory rigor, and sustainability partnerships are defining market leadership and supplier differentiation

A careful examination of incumbent and emerging companies reveals differentiated approaches to technology investment, sustainability positioning, and customer engagement. Leading suppliers are converging on platforms that integrate high-precision molding, advanced barrier solutions, and compatibility testing services to reduce qualification time for customers. Some firms are also forging strategic alliances with recyclers and material innovators to secure feedstock for recycled PET streams and to co-develop pharmaceutical-grade recycled materials that meet extractables and leachables standards.

Contract packaging organizations are investing heavily in automated fill-finish lines and in digital quality management systems that enable traceability and reduce time-to-release. This operational focus is complemented by collaborative R&D programs with pharmaceutical manufacturers to tailor container-closure systems for specific drug chemistries, particularly for biologics and sensitive injectables. New entrants are differentiating through niche offerings such as specialized prefilled device formats or single-use systems engineered for ease of patient self-administration.

Across the competitive landscape, the combination of manufacturing excellence, demonstrable regulatory evidence, and sustainability credentials is becoming the basis for winning long-term partnerships. Companies that can provide integrated solutions encompassing material sourcing, validation support, and logistics services are positioned to capture greater strategic value in customer relationships.

Practical strategic moves for packaging leaders to improve supplier resilience, accelerate sustainable material adoption, and optimize fill-finish manufacturability across portfolios

Industry leaders should pursue a three-pronged action agenda that aligns technical capability, supply chain resilience, and sustainability pathways. First, prioritize cross-functional qualification programs that reduce supplier risk through dual sourcing and modular validation protocols, thereby shortening the time required to transition between suppliers while preserving product quality. Investing in validation toolkits and shared trial frameworks enables faster onboarding and decreases the operational disruption of supplier changes.

Second, accelerate adoption of design-for-manufacturability principles that reconcile barrier performance with recyclability objectives. This includes adopting neck finishes and closure interfaces that are compatible with automated fill-finish lines, and working with material scientists to specify PET formulations or coatings that meet extractables standards while facilitating circularity through mechanical or chemical recycling routes. Collaborative pilot projects with recyclers and converters can yield scalable proofs of concept that inform procurement standards.

Third, embed trade policy and regional risk assessment into strategic sourcing decisions by mapping supplier exposure to tariff shifts and logistical bottlenecks. Scenario planning and contractual clauses that allocate risk in defined ways can protect operations, while investments in regional tooling and localized production can serve as effective hedges. Executing on these recommendations will require cross-disciplinary governance, measurable KPIs, and a clear roadmap for iterative improvement.

A rigorous mixed-methods research approach integrating expert interviews, technical literature, and supply chain evidence to produce actionable and verifiable packaging insights

The research underpinning this analysis combined a multi-method approach to ensure balanced, evidence-based conclusions. Primary data were gathered through interviews with packaging engineers, regulatory affairs specialists, procurement leaders, and R&D heads across pharmaceutical manufacturers and contract packagers, providing firsthand perspectives on material performance, qualification requirements, and operational constraints. These qualitative inputs were triangulated with technical literature on polymer chemistry, regulatory guidances on container compatibility, and publicly available product specifications to validate material performance claims and compatibility assertions.

Secondary analysis included a systematic review of patent activity, industry announcements, and reported capital investments in fill-finish automation to identify technology trajectories and investment priorities. The methodology emphasized contextualization rather than projection, focusing on observed changes in supplier behavior, validation practices, and regional sourcing strategies. Throughout the study, attention was paid to ensuring that sustainability claims were assessed against verifiable recycling pathways and documented testing regimes rather than marketing narratives.

Data interpretation prioritized actionable insight: findings were organized to support procurement decisions, product development roadmaps, and regulatory planning. Limitations of the research are acknowledged in areas where proprietary testing data or confidential supplier agreements limited visibility, and recommendations include targeted steps to close these evidence gaps through collaborative trials and supplier data sharing.

A consolidated synthesis of how technological progress, regulatory expectations, and sustainability commitments are jointly shaping PET packaging strategies for pharma leaders

PET packaging occupies a pivotal role in modern pharmaceutical logistics and product design, offering a combination of performance, manufacturability, and potential circularity that makes it an attractive alternative across many drug forms. The interplay of evolving regulatory requirements, innovation in material science, and mounting sustainability expectations is driving manufacturers and suppliers to rethink packaging architectures and supplier relationships. While the transition requires careful validation to ensure patient safety and product stability, it also creates opportunities to optimize fill-finish operations, reduce total system cost, and meet stakeholder expectations around environmental performance.

The cumulative picture is one of pragmatic transformation: incremental technical advances and operational investments are enabling broader adoption of PET across formats while preserving the evidentiary rigor required by regulators. For strategic leaders, the imperative is to align packaging choice with broader business objectives-balancing speed to market, patient-centric design, and long-term sustainability commitments. The insights presented here are intended to inform those decisions and to provide a foundation for targeted pilots, supplier collaborations, and investment choices that can yield measurable business and environmental outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PET Packaging In the Pharmaceutical Market, by Packaging Type

  • 8.1. Ampoules & Vials
  • 8.2. Blister Packs
  • 8.3. Bottles
    • 8.3.1. Multi-Dose Bottles
    • 8.3.2. Single-Dose Bottles
  • 8.4. Syringes & Cartridges
    • 8.4.1. Cartridges
    • 8.4.2. Pre-Filled Syringes

9. PET Packaging In the Pharmaceutical Market, by Drug Type

  • 9.1. Injectables
  • 9.2. Liquids
  • 9.3. Nutraceuticals
  • 9.4. Powders
  • 9.5. Tablets & Capsules
    • 9.5.1. Capsules
    • 9.5.2. Tablets

10. PET Packaging In the Pharmaceutical Market, by Fill-Finish

  • 10.1. Automatic
  • 10.2. Manual

11. PET Packaging In the Pharmaceutical Market, by Sustainability Solution

  • 11.1. Recycled PET
    • 11.1.1. Chemical Recycled
    • 11.1.2. Mechanical Recycled
  • 11.2. Virgin PET
    • 11.2.1. Extrusion Blow Mould
    • 11.2.2. Injection Mould

12. PET Packaging In the Pharmaceutical Market, by End User

  • 12.1. Home Healthcare
  • 12.2. Hospitals & Clinics
  • 12.3. Retail Pharmacies

13. PET Packaging In the Pharmaceutical Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. PET Packaging In the Pharmaceutical Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. PET Packaging In the Pharmaceutical Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States PET Packaging In the Pharmaceutical Market

17. China PET Packaging In the Pharmaceutical Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ALPLA Werke Alwin Lehner GmbH & Co KG
  • 18.6. Amcor plc
  • 18.7. AptarGroup, Inc.
  • 18.8. Berry Global, Inc.
  • 18.9. Catalent, Inc.
  • 18.10. CCL Industries Inc.
  • 18.11. Constantia Flexibles GmbH
  • 18.12. Drug Plastics & Glass Co., Inc
  • 18.13. Gerresheimer AG
  • 18.14. Graham Packaging Company
  • 18.15. Klockner Pentaplast Group GmbH & Co. KG
  • 18.16. Nipro Corporation
  • 18.17. Plastipak Packaging, Inc.
  • 18.18. Silgan Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AMPOULES & VIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AMPOULES & VIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AMPOULES & VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MULTI-DOSE BOTTLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MULTI-DOSE BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MULTI-DOSE BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SINGLE-DOSE BOTTLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SINGLE-DOSE BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SINGLE-DOSE BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY LIQUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY LIQUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY NUTRACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY NUTRACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CHEMICAL RECYCLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CHEMICAL RECYCLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CHEMICAL RECYCLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MECHANICAL RECYCLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MECHANICAL RECYCLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MECHANICAL RECYCLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY EXTRUSION BLOW MOULD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY EXTRUSION BLOW MOULD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY EXTRUSION BLOW MOULD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTION MOULD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTION MOULD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTION MOULD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 243. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 244. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 245. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)